Compare ALEMBIC with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs DISHMAN PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC DISHMAN PHARMA ALEMBIC/
DISHMAN PHARMA
 
P/E (TTM) x 79.5 25.1 316.9% View Chart
P/BV x 6.9 3.3 204.8% View Chart
Dividend Yield % 0.1 0.7 22.4%  

Financials

 ALEMBIC   DISHMAN PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
DISHMAN PHARMA
Mar-16
ALEMBIC/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs72374 19.2%   
Low Rs34129 26.3%   
Sales per share (Unadj.) Rs4.7197.8 2.4%  
Earnings per share (Unadj.) Rs6.121.2 28.8%  
Cash flow per share (Unadj.) Rs6.234.7 18.0%  
Dividends per share (Unadj.) Rs0.202.00 10.0%  
Dividend yield (eoy) %0.40.8 47.5%  
Book value per share (Unadj.) Rs40.7179.9 22.6%  
Shares outstanding (eoy) m267.0380.69 330.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.3 885.4%   
Avg P/E ratio x8.711.9 73.1%  
P/CF ratio (eoy) x8.57.2 117.0%  
Price / Book Value ratio x1.31.4 93.1%  
Dividend payout %3.39.4 34.7%   
Avg Mkt Cap Rs m14,13920,306 69.6%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m2075,355 3.9%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m1,25515,961 7.9%  
Other income Rs m370265 139.5%   
Total revenues Rs m1,62516,226 10.0%   
Gross profit Rs m1114,103 2.7%  
Depreciation Rs m381,091 3.5%   
Interest Rs m2944 0.2%   
Profit before tax Rs m4422,334 18.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2121 110,181.8%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24624 3.8%   
Profit after tax Rs m1,6301,711 95.3%  
Gross profit margin %8.925.7 34.4%  
Effective tax rate %5.426.7 20.3%   
Net profit margin %129.810.7 1,211.2%  
BALANCE SHEET DATA
Current assets Rs m1,86711,018 16.9%   
Current liabilities Rs m5919,517 6.2%   
Net working cap to sales %101.69.4 1,080.9%  
Current ratio x3.21.2 272.8%  
Inventory Days Days94110 85.3%  
Debtors Days Days7435 211.1%  
Net fixed assets Rs m1,79116,304 11.0%   
Share capital Rs m534161 330.9%   
"Free" reserves Rs m10,32412,907 80.0%   
Net worth Rs m10,85814,516 74.8%   
Long term debt Rs m414,189 1.0%   
Total assets Rs m11,59129,805 38.9%  
Interest coverage x260.93.5 7,516.1%   
Debt to equity ratio x00.3 1.3%  
Sales to assets ratio x0.10.5 20.2%   
Return on assets %14.18.9 158.0%  
Return on equity %15.011.8 127.3%  
Return on capital %15.217.5 86.6%  
Exports to sales %1.524.8 6.2%   
Imports to sales %21.03.7 561.5%   
Exports (fob) Rs m193,956 0.5%   
Imports (cif) Rs m263596 44.2%   
Fx inflow Rs m194,952 0.4%   
Fx outflow Rs m264697 37.9%   
Net fx Rs m-2444,255 -5.7%   
CASH FLOW
From Operations Rs m2362,786 8.5%  
From Investments Rs m-224-1,529 14.7%  
From Financial Activity Rs m-27-941 2.8%  
Net Cashflow Rs m-15316 -4.7%  

Share Holding

Indian Promoters % 64.0 61.4 104.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 3.7 5.4%  
FIIs % 9.7 12.7 76.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 22.1 118.1%  
Shareholders   54,701 46,261 118.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   NEULAND LABS  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare ALEMBIC With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 6, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS